What Schedule Is GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE?
GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE scheduling and classification across Australia, United States, and international jurisdictions. Also known as Leader Mucus Relief D.
GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE (Leader Mucus Relief D) is classified as S3 (Pharmacist Only Medicine - available without a prescription but requires pharmacist involvement and may require consultation) under the Therapeutic Goods Administration (TGA) in Australia. It is FDA approved in the United States.
Key Takeaways
- Australia (TGA): S3 - Pharmacist Only Medicine - available without a prescription but requires pharmacist involvement and may require consultation
- United States (FDA): Approved (Rx only)
- Risk level: Low (1 points)
Scheduling by Jurisdiction
| Jurisdiction | Regulatory Body | Classification | Status |
|---|---|---|---|
| Australia | TGA (Therapeutic Goods Administration) | S3 | Not PBS listed |
| United States | FDA / DEA | Rx only (not DEA scheduled) | FDA approved |
What S3 Means for GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE
GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE is classified as S3 under the TGA Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP). Pharmacist Only Medicine - available without a prescription but requires pharmacist involvement and may require consultation.
Claims and Workers Compensation Implications
When GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE (S3) appears on a claimant's medication list, the scheduling classification affects how claims professionals should assess and manage the claim.
Need to assess this medication across your caseload?
Check GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE scheduling, interactions, and compliance across your claimant's full medication list.
AllMeds gives you instant risk assessments, compliance checks, and automated letters for every medication on a claim.
No credit card required. No signup for your first 2 questions.
Related Resources
Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.